about
Inhibition of immune functions by antiviral drugs.Chicken pox in pregnancy : an obstetric concernValaciclovir (BW256U87): the L-valyl ester of acyclovir.Herpes simplex virus infections of women and their offspring: implications for a developed society.Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses.Resistance of herpesviruses to antiviral drugsHIV-related infections of the oral cavity.Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.Varicella pneumonia complicating pregnancy: a report of seven casesPharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients.Oral acyclovir therapy for varicella and zoster infections in pediatric and pregnant patients: a brief review.Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs.HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasionHerpes zoster oticus: A rare clinical entity.Cytomegalovirus and other herpesviruses infections in heart and bone marrow transplant recipients.Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.Selective anabolism of 6-methoxypurine arabinoside in varicella-zoster virus-infected cells.In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.A randomized double-blind placebo controlled trial of oral acyclovir in renal allograft recipients.A description of the gender differences in risk behaviors in young adults with genital herpes.The use of cyclosporin-A in the treatment of virus-associated hemophagocytic syndrome in adults.Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.Herpes simplex virus infections during the decade since the licensure of acyclovir.Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.Antiviral drug sensitivity in ocular herpes simplex virus infection.Kinetic studies with N2-phenylguanines and with L-thymidine indicate that herpes simplex virus type-1 thymidine kinase and thymidylate kinase share a common active siteIrreversible neurotoxicity with acyclovir treatment of acute retinal necrosis.Herpes zoster oticus: treatment with acyclovir.Improved neurodevelopmental outcomes following long-term high-dose oral acyclovir therapy in infants with central nervous system and disseminated herpes simplex disease.Multiple oral dosing of valacyclovir in horses and ponies.Perceived stressors and coping responses in persons with recurrent genital herpes.
P2860
Q34264407-C45D6D08-874C-4A5A-915D-0706C69DF348Q34635786-D6CCAA9C-89ED-4ABD-ACD0-5BD623847A30Q34728688-C1958B53-91D2-4CEB-910C-913AD4D0AC58Q35114519-5D76C4C3-3DA0-47E8-BC56-755377749353Q35244752-CD23396E-6E61-4B38-9469-EE64A5842344Q35328407-368C8D42-E287-45C7-A3CF-26BA9B4E8E73Q35354084-5E53F244-210C-49DB-AB87-91B3AD58826CQ35447500-CA318DD2-590E-44C3-8ADD-515D7B42B772Q36043918-FF2C19EB-A754-4610-9E59-C18C623A6CEEQ36401565-58BDA296-C3B4-46CF-AEF7-3EF95E07A04DQ36625187-DBE4AC8B-AA32-4C32-8A2C-5E14081AA427Q36753818-4A3A41DC-3A55-432C-A914-437FEDFA5CEFQ36800589-F6D77C4F-D642-44A5-9123-6F85FF35B968Q36829250-0AC5813D-746E-4FD3-875B-F2F0D33A8005Q37253362-753ABEF0-E1DA-4F43-8EFE-81C85831A370Q39225983-77A05AF8-587B-4B58-8C0D-65BA0F12BEA5Q39584883-3F03798E-633F-4209-A7E0-2248CBFFD076Q39848481-10929D66-6239-495C-953B-34DD7D70340BQ39882007-50DD286B-BB9F-476B-8900-86DFD7FF8747Q40087739-4B84EBFE-D8A4-4B99-B147-09CC826C63E5Q40088021-EEBCC708-2B66-4039-B44E-8A6A3E538E45Q40141163-DDAF1233-7132-4EC5-8A70-8B43D4CA385FQ40518919-7179ED31-0565-4EF1-B5C0-970583DFB829Q40641188-C07569DD-FD0B-40BA-9586-CA8E85ACE54DQ40669532-E91DA525-4C77-41F7-818F-DB2942340E83Q40782534-A1B6D643-07F2-45A6-A855-41C7A271847BQ41761307-15347692-2D64-4664-9902-A408FACEB184Q42038288-2A41EAFB-727A-437B-A172-C1446C0B0FC1Q42828803-EB36104B-9CC5-4ACA-B3D9-295FF9FF9542Q43876236-1A7BEAFE-7731-477F-ACB6-ADA7D88C0D21Q44924965-7A94C4A1-B48C-4F69-8756-C6F8BD90BCDDQ45190991-8F20C022-3C4B-4ED1-9C12-D21567AFE1BCQ45914766-DF944A84-F668-4A3A-9AE9-E3DA7BAF7972Q51155465-B52BED10-60C7-4DA9-9462-5529A6E7EFA5
P2860
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Drugs five years later: acyclovir.
@en
Drugs five years later: acyclovir.
@nl
type
label
Drugs five years later: acyclovir.
@en
Drugs five years later: acyclovir.
@nl
prefLabel
Drugs five years later: acyclovir.
@en
Drugs five years later: acyclovir.
@nl
P1476
Drugs five years later: acyclovir.
@en
P2093
Crumpacker CS
P304
P356
10.7326/0003-4819-107-6-859
P407
P577
1987-12-01T00:00:00Z